Fady Ibraham Malik

EVP Research & Development, Cytokinetics

Bought, 12 months

$0.0M

Sold, 12 months

$4.8M

Companies

Latest trade

Oct 20, 2026

Companies

CytokineticsEVP Research & Development −$5.1M

Trades

CYTK Sold 3,500 shares at $64.01 · planned $0.2M Oct 20

CYTK Sold 3,500 shares at $61.38 · planned $0.2M Oct 6

CYTK Sold 3,500 shares at $68.29 · planned $0.2M Sep 22

CYTK Sold 3,500 shares at $75.46 · planned $0.3M Sep 8

CYTK Sold 3,500 shares at $75.82 · planned $0.3M Aug 18

CYTK Sold 3,500 shares at $80.59 · planned $0.3M Jul 21

CYTK Sold 3,500 shares at $86.62 · planned $0.3M Jul 7

CYTK Sold 3,500 shares at $79.51 · planned $0.3M Jun 23

CYTK Sold 3,500 shares at $67.98 · planned $0.2M Jun 9

CYTK Sold 3,500 shares at $75.69 · planned $0.3M May 19

CYTK Sold 3,500 shares at $77.37 · planned $0.3M May 5

CYTK Sold 3,500 shares at $65.69 · planned $0.2M Apr 21

CYTK Sold 4,500 shares at $65.11 · planned $0.3M Apr 7

CYTK Sold 12,033 shares at $62.15 $0.7M Mar 17

CYTK Sold 2,907 shares at $60.72 $0.2M Mar 9

CYTK Sold 2,200 shares at $61.24 · planned $0.1M Dec 16

CYTK Sold 2,200 shares at $63.89 · planned $0.1M Dec 2

CYTK Sold 2,200 shares at $66.45 · planned $0.1M Nov 18

CYTK Sold 2,295 shares at $59.55 · planned $0.1M Nov 4

CYTK Sold 2,105 shares at $58.22 · planned $0.1M Oct 21

CYTK Sold 2,000 shares at $60.56 · planned $0.1M Oct 7

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.